Breaking News
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Innovative strategy opens up new avenue of treatment for anthrax infections
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making

Hyperthyroidism and Graves’ Disease

image_pdfDownload PDFimage_print

What Is the Thyroid?

The thyroid is a small gland below the skin and muscles at the front of the neck, at the spot where a bow tie would rest.

It’s brownish red, with left and right halves (called lobes) that look like a butterfly’s wings. It weighs less than an ounce, but helps the body do many things, such as get energy from food, grow, and go through sexual development.

What Is Hyperthyroidism?

Thyroid hormone problems happen when the thyroid gland makes either too much or too little hormone for the body.

If the thyroid is overactive, it releases too much thyroid hormone into the bloodstream, causing hyperthyroidism. The body use up energy more quickly than it should, and chemical activity (like metabolism) in the cells speeds up.

If the thyroid is underactive, it makes too little thyroid hormone, causing hypothyroidism. The body uses up energy more slowly, and chemical activity (metabolism) in the cells slows down.

What Are the Signs & Symptoms of Hyperthyroidism?

High thyroid hormone levels (hyperthyroidism) can cause:

  • nervousness
  • irritability
  • increased sweating
  • bulging eyes
  • trouble sleeping
  • a fast heartbeat
  • irregular menstrual periods in girls
  • weight loss

Sometimes the thyroid gland grows and forms a bulge in the neck called a goiter.

Medicines and other techniques can effectively treat hyperthyroidism. It’s important to work with an

(a doctor who specializes in hormone problems) or other doctor who knows how to treat thyroid conditions.

What Causes Hyperthyroidism?

The three main causes of hyperthyroidism are:

  1. Graves’ disease. This is the most common cause of hyperthyroidism in children. It happens when the body produces antibodies that make the thyroid gland overactive. Antibodies usually help the body fight infection, but these antibodies stop the body from controlling the thyroid gland correctly (like a car without brakes). As a result, the thyroid hormone levels in the blood can get very high. Doctors don’t know why the body starts making these antibodies. Graves’ disease can affect health for the rest of a person’s life. So it’s important to get medical treatment to control it.
  2. Thyroid gland inflammation (thyroiditis). This causes the thyroid gland to leak too much thyroid hormone into the blood. Thyroiditis can be caused by a lots of things — for example, a blow to the thyroid gland, infections, and
    diseases (like Hashimoto’s thyroiditis). Hyperthyroidism from thyroiditis usually lasts for a few months and then gets better on its own. The thyroid usually recovers, but sometimes is damaged and can’t work normally again. This causes hypothyroidism (underactive thyroid).
  3. Thyroid nodules (growths in the thyroid gland). These can sometimes make large amounts of thyroid hormones, causing symptoms of hyperthyroidism. Overactive thyroid nodules are usually large (an inch or more in size) and can be big enough to feel in the neck. Most overactive thyroid nodules are 
    and treated with surgery.

What Are the Signs & Symptoms of Graves’ Disease?

Kids and teens with Graves’ disease might notice that:

  • they’re more tired than usual
  • they have lots of trouble sleeping
  • they lose weight
  • their heart is beating very fast
  • their hands shake (called tremor)
  • they have a lot of trouble focusing

Girls with Graves’ disease sometimes notice that they have fewer (or less regular) menstrual cycles. Over time, many people notice that their thyroid glands are enlarged.

Some people with Graves’ disease have troubles with their eyes — itching, burning, redness, and sometimes trouble seeing normally. Sometimes they feel pressure behind the eyes, feel their eyes bulging, or see double. This is because the antibodies that make the thyroid overactive also cause

and swelling behind the eyes. When this happens, it’s called Graves’ eye disease.

How Is Graves’ Disease Diagnosed?

Graves’ disease is diagnosed based on a visit with a doctor who will review the symptoms and examine the patient.

It’s important to do lab tests too, because many people can have some of the symptoms of hyperthyroidism for other reasons. Sometimes the blood tests aren’t enough to be sure of the diagnosis and other tests are needed, like a thyroid scan or ultrasound.

How Is Graves’ Disease Treated?

Doctors usually treat Graves’ disease with anti-thyroid medicines. These medicines slow the release of thyroid hormones from the gland. They usually bring hormone levels down to normal within a couple of months.

Many people with Graves’ disease need to take anti-thyroid medicines for a long time to control the condition — sometimes for the rest of their lives.

Some might need other treatment if anti-thyroid medicines don’t help or cause side effects, or if the disease is very hard to control. In these cases, two permanent treatment options can be used: radioactive iodine treatment and surgery.

Radioactive iodine (RAI) is the most commonly used permanent treatment for Graves’ disease. RAI damages the thyroid gland so that it can’t make too much thyroid hormone. This doesn’t harm other parts of the body. The RAI treatment is taken in capsules or mixed with a glass of water. The thyroid gland quickly absorbs the RAI from the bloodstream and, within a few months, the gland shrinks and symptoms slowly disappear.

Surgery to remove most of the thyroid gland is called a thyroidectomy. It’s done in a hospital under general anesthesia, so the person is asleep and feels nothing. A small incision (cut) in the lower central part of the neck usually leaves a thin scar. It’s common to have some pain for a few days after the surgery, but most people feel much better within a few days.

After treatment for hyperthyroidism, hormone production often slows down to hypothyroid (underactive) levels. So the person needs to take a thyroid hormone replacement tablet each day. This treatment is a lot easier to manage than taking pills to control the hyperthyroidism — fewer blood tests, doctor visits, and medicine changes are needed.

As the body adjusts to the hormone replacement tablets, a doctor may increase or reduce the dosage until the levels of thyroid hormone are normal. When the doctor finds the proper dosage, people usually feel well and free of symptoms. The doctor will continue to check hormone levels to make sure the dosage is right, especially for growing teens whose levels might change over just a few months.

What Else Should I Know?

We don’t know why people develop Graves’ disease. But with good medical help, kids and teens can be healthy and do all the things other kids and teens can do.

Graves’ eye disease can develop at any time in someone who has Graves’ disease. Smoke can make this eye disease much worse, so it’s very important to not smoke and to avoid secondhand smoke.

Women with Graves’ disease need to be very careful to keep their hormone levels in balance. Uncontrolled thyroid hormone levels in a pregnant woman can lead to problems during pregnancy and harm her baby.

About author

Related Articles